Dana Blankenhorn

Dana Blankenhorn

InvestorPlace Contributor

Expertise: Technology, Biotech, Renewable energy

Education: M.S,J. Northwestern (Medill School) 1978; B.A. Rice University, History and Political Science 1977

Awards & Accomplishments: Tech reporter since 1982, Freelance since 1983, on Internet since 1985. Created first online coverage of Internet with a magazine, Interactive Age, 1994 Co-wrote BBS Systems for Business in 1991, Wrote Guide to Field Computing in 1992 Wrote technology history now called "Living with Moore's Law" in 2001, 2010, 2021 Author of over a dozen books, both fiction and non-fiction

About Dana:
Dana Blankenhorn has been a financial journalist since 1978, a technology journalist since 1982, and an Internet journalist since 1985. He writes a Substack newsletter, Facing the Future, which covers technology, markets, and politics.

He has written a half-dozen technology books, several novels available at the Amazon Kindle store, and covered beats ranging from education to e-commerce, and from open source to renewable energy. He lives in Atlanta.

Recent Articles

The Electric Vehicle Fad Gets Silly With the Workhorse Group

By Dana Blankenhorn, InvestorPlace Contributor

The search is on for the next Tesla and Workhorse Group is among the candidates. But WKHS stock isn't necessarily a Tesla.

Amazon Is the Pandemic’s Wildest Ride

By Dana Blankenhorn, InvestorPlace Contributor

AMZN stock is a buy, as Amazon.com and its infrastructure gather more market and technolgical power than Washington has ever seen.

It May Be Time to Give Up on Cisco Stock

By Dana Blankenhorn, InvestorPlace Contributor

If Cisco Systems were a sports team, CEO Chuck Robbins would be on his way out. But it's not, he's not, so time for you to walk away.

6 Alternatives for Investors Searching How to Buy the Ant Group IPO

By Dana Blankenhorn, InvestorPlace Contributor

Investors can access Ant Group stock through Alibaba, which owns one-third of it, a Chinese-oriented fund, or by calling some U.S. brokers.

Why Centene Is the Most Important Healthcare Stock

By Dana Blankenhorn, InvestorPlace Contributor

CNC stock holders found a company like Tesla in that it has a better technology than its rivals, in this case in managed healthcare.

Despite Its High Price, Analysts Say Buy Tesla

By Dana Blankenhorn, InvestorPlace Contributor

Batteries turn out to be the key to success in the electric car market. That's the technology Tesla now dominates.

Why Buy a Yield Trap With AT&T?

By Dana Blankenhorn, InvestorPlace Contributor

AT&T stock yields over 7%. It needs to be broken up, and when it is the capital gains could be tremendous.

Why Evernorth May Not Resolve Cigna’s Long-Term Issues

By Dana Blankenhorn, InvestorPlace Contributor

Analysts are telling investors to buy Cigna stock, but there are reasons to question the long-term future of the health insurer.

Humana’s Pretty Good Year Reflects a Surprising Side to the Health Crisis

By Dana Blankenhorn, InvestorPlace Contributor

Humana is hoping to gain big contracts from the military and improve its share of the Medicare Advantage market.

Best ETFs for 2020: A Hard CLOU Fall

By Dana Blankenhorn, InvestorPlace Contributor

The CLOU ETF is not designed for traders, but for investors following the length and breadth of the cloud application trend.

Load More